XML 81 R67.htm IDEA: XBRL DOCUMENT v3.23.1
SHAREHOLDERS' EQUITY - Summary Of Employee Options Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 29, 2022
Dec. 31, 2022
Dec. 31, 2021
Number of options      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 160,576    
Share-based Payment Arrangement, Option      
Number of options      
Outstanding, balance   4,717,200  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross   647,217  
Exercised   (209,839)  
Forfeited   (822,556)  
Outstanding, balance   4,332,022 4,717,200
Exercisable options at the end of the year   3,304,097  
Options vested and expected to vest at the end of the year   4,290,241  
Weighted average exercise price      
Outstanding, weighted average exercise price   $ 101.66  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price     $ 119.62
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price     24.64
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price     175.19
Outstanding, weighted average exercise price   94.11 $ 101.66
Exercisable, weighted average exercise price   76.80  
Options vested and expected to vest at the end of the year   $ 93.84  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term   5 years 8 months 8 days 6 years 3 months 25 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term   4 years 9 months 21 days  
Outstanding at the beginning of the year, aggregate intrinsic value   $ 339,012  
Outstanding at the ending of the year, aggregate intrinsic value   77,308 $ 339,012
Exercisable, aggregate intrinsic value   76,745  
Options vested and expected to vest at the end of the year, aggregate intrinsic value   $ 77,246